Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 334

1.
2.

Transcription of the herpes simplex virus latency-associated transcript promotes the formation of facultative heterochromatin on lytic promoters.

Cliffe AR, Garber DA, Knipe DM.

J Virol. 2009 Aug;83(16):8182-90. doi: 10.1128/JVI.00712-09. Epub 2009 Jun 10.

3.

The polycomb group protein Bmi1 binds to the herpes simplex virus 1 latent genome and maintains repressive histone marks during latency.

Kwiatkowski DL, Thompson HW, Bloom DC.

J Virol. 2009 Aug;83(16):8173-81. doi: 10.1128/JVI.00686-09. Epub 2009 Jun 10.

4.

Herpesviral ICP0 Protein Promotes Two Waves of Heterochromatin Removal on an Early Viral Promoter during Lytic Infection.

Lee JS, Raja P, Knipe DM.

MBio. 2016 Jan 12;7(1):e02007-15. doi: 10.1128/mBio.02007-15.

5.

Herpesviral latency-associated transcript gene promotes assembly of heterochromatin on viral lytic-gene promoters in latent infection.

Wang QY, Zhou C, Johnson KE, Colgrove RC, Coen DM, Knipe DM.

Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):16055-9. Epub 2005 Oct 24.

6.

Role of polycomb proteins in regulating HSV-1 latency.

Watson Z, Dhummakupt A, Messer H, Phelan D, Bloom D.

Viruses. 2013 Jul 15;5(7):1740-57. doi: 10.3390/v5071740. Review.

7.

Polycomb repressive complex 2 silences human cytomegalovirus transcription in quiescent infection models.

Abraham CG, Kulesza CA.

J Virol. 2013 Dec;87(24):13193-205. doi: 10.1128/JVI.02420-13. Epub 2013 Sep 25.

9.

A novel selective LSD1/KDM1A inhibitor epigenetically blocks herpes simplex virus lytic replication and reactivation from latency.

Liang Y, Quenelle D, Vogel JL, Mascaro C, Ortega A, Kristie TM.

MBio. 2013 Feb 5;4(1):e00558-12. doi: 10.1128/mBio.00558-12.

10.

Epigenetic analysis of KSHV latent and lytic genomes.

Toth Z, Maglinte DT, Lee SH, Lee HR, Wong LY, Brulois KF, Lee S, Buckley JD, Laird PW, Marquez VE, Jung JU.

PLoS Pathog. 2010 Jul 22;6(7):e1001013. doi: 10.1371/journal.ppat.1001013.

11.

Chromatin control of herpes simplex virus lytic and latent infection.

Knipe DM, Cliffe A.

Nat Rev Microbiol. 2008 Mar;6(3):211-21. doi: 10.1038/nrmicro1794. Review.

PMID:
18264117
12.

Long-term promoter activity during herpes simplex virus latency.

Lokensgard JR, Bloom DC, Dobson AT, Feldman LT.

J Virol. 1994 Nov;68(11):7148-58.

13.

Epigenetic regulation of latent HSV-1 gene expression.

Bloom DC, Giordani NV, Kwiatkowski DL.

Biochim Biophys Acta. 2010 Mar-Apr;1799(3-4):246-56. doi: 10.1016/j.bbagrm.2009.12.001. Epub 2010 Jan 4. Review.

15.
16.

Transcription of the herpes simplex virus 1 genome during productive and quiescent infection of neuronal and nonneuronal cells.

Harkness JM, Kader M, DeLuca NA.

J Virol. 2014 Jun;88(12):6847-61. doi: 10.1128/JVI.00516-14. Epub 2014 Apr 9.

17.

Neuronal control of herpes simplex virus latency.

Tenser RB, Edris WA, Hay KA.

Virology. 1993 Aug;195(2):337-47.

PMID:
8393231
18.

The HSV-1 Latency-Associated Transcript Functions to Repress Latent Phase Lytic Gene Expression and Suppress Virus Reactivation from Latently Infected Neurons.

Nicoll MP, Hann W, Shivkumar M, Harman LE, Connor V, Coleman HM, Proença JT, Efstathiou S.

PLoS Pathog. 2016 Apr 7;12(4):e1005539. doi: 10.1371/journal.ppat.1005539. eCollection 2016 Apr 7.

19.

Biphasic euchromatin-to-heterochromatin transition on the KSHV genome following de novo infection.

Toth Z, Brulois K, Lee HR, Izumiya Y, Tepper C, Kung HJ, Jung JU.

PLoS Pathog. 2013;9(12):e1003813. doi: 10.1371/journal.ppat.1003813. Epub 2013 Dec 19.

20.

Dynamic modulation of HSV chromatin drives initiation of infection and provides targets for epigenetic therapies.

Kristie TM.

Virology. 2015 May;479-480:555-61. doi: 10.1016/j.virol.2015.01.026. Epub 2015 Feb 18. Review.

Supplemental Content

Support Center